Probiotic prophylaxis of ventilator-associated pneumonia: A blinded, randomized, controlled trial

American Journal of Respiratory and Critical Care Medicine

Volumn 182, Issue 8, 2010, Pages 1058-1064

  Morrow, Lee E ^a   Kollef, Marin H ^b   Casale, Thomas B ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Bloodstream infection; Clostridium difficile; Lactobacillus; Probiotics; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; INULIN; PLACEBO; PROBIOTIC AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HIGH RISK PATIENT; HUMAN; INFECTION PREVENTION; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VENTILATOR ASSOCIATED PNEUMONIA;

ADULT; AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; LACTOBACILLUS RHAMNOSUS; MALE; MIDDLE AGED; PILOT PROJECTS; PNEUMONIA, VENTILATOR-ASSOCIATED; PROBIOTICS; PROSPECTIVE STUDIES; SAFETY; SURVIVAL ANALYSIS;

EID: 77958006512     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200912-1853OC     Document Type: Article

References (41)

1. Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, Kollef MH; VAP Outcomes Scientific Advisory Group. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:2115-2121.
2. Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, Jaeschke RZ, Brun-Buisson C. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998;129:433-440.
3. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
4. Ibrahim EH, Tracy L, Hill C, Fraser VJ, Kollef MH. The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest 2001;120:555-561.
5. Kollef MH. What is ventilator-associated pneumonia and why is it important? Respir Care 2005;506:714-721.
6. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of healthcare-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005;128:3854-3862.
7. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States: National Nosocomial Infections Surveillance System. Crit Care Med 1999;27:887-892.
8. Kollef MH. Prevention of hospital-associated pneumonia and ventilator-associated pneumonia. Crit Care Med 2004;32:1396-1405.
9. Craven DE. Preventing ventilator-associated pneumonia in adults: sowing seeds of change. Chest 2006;130:251-260.
10. Cook D. Ventilator associated pneumonia: perspectives on the burden of illness. Intensive Care Med 2000;26:S31-S37.
11. Dodek P, Keenan S, Cook D, Heyland D, Jacka M, Hand L, Muscedere J, Foster D, Mehta N, Hall R, et al.; Canadian Critical Care Trials Group. Canadian Critical Care Society. Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann Intern Med 2004;141:305-313.
12. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004;53:1-36.
13. Babcock HM, Zack JE, Garrison T, Trovillion E, Jones M, Fraser VJ, Kollef MH. An educational intervention to reduce ventilator-associated pneumonia in an integrated health system: a comparison of effects. Chest 2004;125:2224-2231.
14. Kollef MH, Afessa B, Anzueto A, Veremakis C, Kerr KM, Margolis BD, Craven DE, Roberts PR, Arroliga AC, Hubmayr RD, et al.; NASCENT Investigation Group. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008;300:805-813.
15. Guidelines for the evaluation of probiotics in food: report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food (accessed October 3, 2009) Available from: http://www.who.int/foodsafety/ fs-management/en/probiotic-guidelines.pdf
16. Ghosh S, van Heel D, Playford RJ. Probiotics in inflammatory bowel disease: it is all gut flora modulation? Gut 2004;53:620-622.
17. McNaught CE, Woodcock NP, MacFie J, Mitchell CJ. A prospective randomized study of the probiotic Lactobacillus plantarum 299V on indices of guy barrier function in elective surgical patients. Gut 2002;51:827-831.
18. van der Kleij D, Latz E, Brouwers JF, Kruize YC, Schmitz M, Kurt-Jones EA, Espevik T, de Jong EC, Kapsenberg ML, Golenbock DT, et al. A novel host-parasite lipid cross-talk: schistosomal lystophosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem 2002;277:48122-48129.
19. Chapat L, Chemin K, Dubois B, Bourdet-Sicard R, Kaiserlian D. Lactobacillus casei reduces CD8+ T cell-mediated skin inflammation. Eur J Immunol 2004;34:2520-2528.
20. Isolauri E, Sutas Y, Kanaanpaa P, Arvilommi J, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr 2001;73:444S-450S.
21. Walker WA. Mechanisms of action of probiotics. Clin Infect Dis 2008;46:S87-S91.
22. Wolvers D, Antoine JM, Myllyluoma E, Schrezenmeir J, Szajewska H, Rijkers JT. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics. J Nutr 2010;140:698S-712S.
23. Pitsouni E, Alexious V, Saridakis V, Peppas G, Falagas M. Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials. Eur J Pharmacol 2009;65:561-570.
24. Knight DJ, Gardiner D, Banks A, Snape SE, Weston VC, Bengmark S, Girling KJ. Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial. Intensive Care Med 2009;35:854-861.
25. van Santvoort HC, Besselink MG, Timmerman HM, van Minnen LP, Akkermans LM, Gooszen HG. Probiotics in surgery. Surgery 2008;143:1-7.
26. Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, Bengmark S, Neuhaus P. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation: a randomized, double-blind trial. Am J Transplant 2005;5:125-130.
27. Falcao de Arruda IS, de Aguilar-Nascimenta JE. Benefits of early enteral nutrition with glutamine and probiotics in brain injury patients. Clin Sci 2004;106:287-292.
28. Morrow LE. Probiotic manipulation of the endogenous flora as prophylaxis for ventilator-associated pneumonia. J Investig Med 2008;56:658-659.
29. Morrow LE, Kollef MH, Bowers JB, Casale TB. Probiotic manipulation of the native flora in critically ill patients: an opportunity for ventilator-associated pneumonia prophylaxis? Chest 2005;128:144S.
30. Kollef MH, Bock KR, Richards RD, Hearns ML. The safety and diagnostic accuracy of minibronchoalveolar lavage in patients with suspected ventilator-associated pneumonia. Ann Intern Med 1995;122:743-748.
31. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-556.
32. Forestier C, Guelon D, Cluytens V, Gillart T, Sirot J, De Champs C. Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo controlled pilot study in intensive care unit patients. Crit Care 2008;12:R69.
33. Klarin B, Molin G, Jeppson B, Larsson A. Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomized controlled open pilot study. Crit Care 2008;12:R136.
34. Spindler-Vesel A, Benkgmark S, Vovk I, Cerovic O, Kompan L. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. J Parenter Enteral Nutr 2007;31:119-126.
35. Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, Kazamanias P, Eleftheriadis E. Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically ill trauma patients: early results of a randomized controlled trial. World J Surg 2006;30:1848-1855.
36. Siempos II, Ntaidou TK, Falagas ME. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized, controlled trials. Crit Care Med 2010;38:954-962.
37. Gluck U, Gebbers JO. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and β-hemolytic streptococci). Am J Clin Nutr 2003;77:517-520.
38. Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, Nase L, Saxelin M, Korpela R. Effect of long-term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 2001;322:1327-1329.
39. Brandtzaeg P. Humoral immune response patterns of human mucosae: induction and relation to bacterial respiratory tract infections. J Infect Dis 1992;165:S167-S176.
40. Besselink MGH, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008;371:651-659.
41. The Editors of the Lancet. Expression of concern: probiotic prophylaxis in predicted severe acute pancreatitis: a randomized, double-blind, placebo-controlled trial. Lancet 2010;375:875-876.